Please Wait.....
Report
North America Wound Care Management - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-06-01 I 85 Pages I Mordor Intelligence
North America Wound Care Management Market Analysis
The North America wound care management market is valued at USD 5.53 billion in 2025 and is forecast to reach USD 6.56 billion by 2030, reflecting a 3.5% CAGR. Demand is anchored in the rising prevalence of chronic wounds among an aging population, combined with higher diabetes incidence and obesity rates across the region. Hospitals continue to adopt negative-pressure and hyperbaric oxygen therapies, yet portable systems are quickly expanding indications into home settings, widening patient access. Specialty biologics and smart dressings are gaining momentum as reimbursement clarity improves and clinical evidence strengthens. Competitive strategies revolve around portfolio consolidation, integration of digital wound imaging, and targeted penetration of under-served markets such as Mexico, where advanced solutions are still in the early-stage adoption phase.
North America Wound Care Management Market Trends and Insights
Demographic Shift: Rapid Growth of 65-Plus Population
The North America wound care management market benefits from a steady rise in the 65-plus age cohort, which faces higher chronic wound incidence because of skin fragility, vascular disease, and poly-morbid conditions. Mortality after diabetes-related lower-limb amputation exceeds 70% at five years, underlining the severe burden in older patients . Health systems are revising protocols to emphasize prevention, early intervention, and the use of advanced dressings that shorten healing cycles. Suppliers are adapting portfolios toward easy-to-apply, longer-wear dressings and telemetry-enabled monitoring so that geriatric patients can be managed safely at home. Over the long term, this demographic trend sustains baseline demand even as individual product pricing moderates.
Diabetes-Linked Foot Ulcers: Rising Prevalence Among Hispanic Populations
Foot ulcer risk now affects up to one-third of people with diabetes, and amputation rates remain disproportionately high in Hispanic and Indigenous communities. In Mexico, diabetes prevalence reaches 18.3%, amplifying the clinical and economic importance of timely ulcer care . Manufacturers are partnering with public health agencies to deliver culturally tailored education and affordable dressings. Evidence-based programs that combine off-loading, infection control, and negative-pressure therapy are scaling within Mexican public clinics, reflecting a strategic push to capture untapped demand while reducing limb-loss rates.
High Cost of Advanced Wound-Care Products Limiting Uptake
Premium pricing curtails expansion of biologic dressings and device-based therapies, especially in budget-constrained facilities and in Mexico, where advanced products have penetrated only 25-30% of eligible cases. Lower resource hospitals often default to traditional gauze, extending healing times and total care costs. To ease budget impact, suppliers are introducing smaller pack sizes and value-based contracting tied to documented healing outcomes, while payers evaluate bundled payments encouraging cost-effective modality selection.
Other drivers and restraints analyzed in the detailed report include:
Escalating Burden of Diabetes and Obesity / Medicare Reimbursement Updates: Policy Shifts Favor Advanced Therapies / Regulatory Complexity Delays Market Access /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Therapy devices accounted for 32% of the North America wound care management market in 2024, anchored by widespread use of negative-pressure systems that draw strong clinical endorsement and robust reimbursement. Innovations such as single-use portable NPWT devices extend wear time to seven days and permit early discharge, directly supporting the migration of chronic wound care into community settings. Traditional dressings remain common for lower-severity wounds, sustaining material volume even as per-unit prices fall.
Active & biologic therapies post the fastest 4.1% CAGR through 2030, propelled by 3-D bioprinted skin substitutes that improve graft integration and reduce infection. Under CMS's upcoming coverage limits, products backed by high-quality evidence will capture a larger slice of the North America wound care management market. Suppliers are bundling biologics with intelligent sensors that track moisture and pH, enabling clinicians to adjust treatment without dressing removal, a feature that supports premium pricing.
Chronic wounds held 62% of revenue in 2024, confirming their central role in the North America wound care management market. Diabetic foot ulcers expand the fastest at 4.5% CAGR, influenced by growing diabetes prevalence and vascular comorbidities. Prevention programs emphasize off-loading and tight glycemic control, yet ulcer recurrence remains high, sustaining demand for biologic matrices that stimulate granulation tissue.
Acute wounds-surgical incisions, burns, and trauma-maintain steady contribution as surgical procedure volumes rebound post-pandemic. Studies integrating NPWT with silver nanoparticle dressings report stronger skin-graft adherence and reduced systemic inflammation. Such evidence encourages multi-modal kits that command premium margins in the North America wound care management market.
The Report Covers Wound Care Companies in North America, and the Market is Segmented by Product (Advanced Wound Dressings, Traditional Wound Care, and More), Wound Type (Chronic Wounds, and Acute Wounds), End User (Hospital & Clinics, Ambulatory Surgical Centers, and More), Mode of Purchase (Prescription-Based, and Over-The-Counter), and Country. The Market Provides the Value (in USD Million) for the Above-Mentioned Segments.
List of Companies Covered in this Report:
3M (incl. Acelity/KCI) / Smiths Group / Johnson&Johnson / Molnlycke Health Care / Convatec / Coloplast / Medtronic / Baxter / Beckton Dickinson / Cardinal Health / Integra LifeSciences / Hollister / Medline Industries / Organogenesis / MiMedx Group Inc. / Derma Sciences (An Integra Brand) / Urgo Medical / Advancis Medical / B. Braun / Axio Biosolutions / Essity (Leukoplast) / Triad Life Sciences /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Demographic Shift: Rapid Growth of 65-Plus Population i
4.2.2 Sharp Uptick in Diabetes-Linked Foot Ulcers, Especially Among Hispanic Populations
4.2.3 Escalating burden of diabetes and obesity fueling chronic wound incidence across North America
4.2.4 Favorable Medicare and private?payer reimbursement updates for NPWT and bio-engineered skin substitutes
4.2.5 Rising surgical procedure volumes (orthopedic, cardiovascular) requiring post-operative wound management
4.2.6 Technological innovations-smart dressings and AI-enabled wound imaging-boosting clinical adoption
4.3 Market Restraints
4.3.1 High cost of advanced wound-care products limiting uptake in budget-constrained facilities
4.3.2 Stringent and heterogeneous regulatory pathways across the United States, Canada, and Mexico delaying approvals
4.3.3 Shortage of specialized wound-care clinicians impeding optimal product utilization
4.3.4 Counterfeit Traditional Dressings in Mexico Undercutting Premium Brands
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Outlook
4.6 Technological Outlook
4.7 Porter's Five Forces Analysis
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Buyers
4.7.3 Bargaining Power of Suppliers
4.7.4 Threat of Substitute Products
4.7.5 Intensity of Competitive Rivalry
5 Market Size & Growth Forecasts (Value / Volume)
5.1 By Product
5.1.1 Advanced Wound Dressings
5.1.1.1 Hydrocolloid Dressings
5.1.1.2 Foam Dressings
5.1.1.3 Film Dressings
5.1.1.4 Alginate Dressings
5.1.1.5 Hydrogel Dressings
5.1.1.6 Collagen Dressings
5.1.1.7 Antimicrobial & Anti-Biofilm Dressings
5.1.2 Traditional Wound Care
5.1.2.1 Gauze
5.1.2.2 Bandages
5.1.2.3 Fixation Tapes & Pads
5.1.3 Therapy Devices
5.1.3.1 Negative Pressure Wound Therapy (NPWT)
5.1.3.2 Hyperbaric Oxygen Therapy (HBOT)
5.1.3.3 Electrical Stimulation Devices
5.1.3.4 Ultrasonic & Other Energy-based Devices
5.1.4 Wound Closure Products
5.1.4.1 Sutures
5.1.4.2 Surgical Staplers
5.1.4.3 Tissue Adhesives, Sealants & Glues
5.1.5 Active & Biologic Therapies
5.1.5.1 Skin Substitutes & Bio-engineered Tissues
5.1.5.2 Growth Factors & Cell-based Therapies
5.1.6 Topical Agents
5.1.6.1 Antiseptic Creams & Ointments
5.1.6.2 Moisturizers & Other Support Products
5.2 By Wound Type
5.2.1 Chronic Wounds
5.2.1.1 Diabetic Foot Ulcer
5.2.1.2 Pressure Ulcer
5.2.1.3 Venous & Arterial Ulcer
5.2.1.4 Other Chronic Wounds
5.2.2 Acute Wounds
5.2.2.1 Surgical Wounds
5.2.2.2 Burns
5.2.2.3 Traumatic & Other Acute Wounds
5.3 By End User
5.3.1 Hospitals & Clinics
5.3.2 Ambulatory Surgical Centers (ASCs)
5.3.3 Home Healthcare Settings
5.3.4 Long-Term Care & Skilled Nursing Facilities
5.3.5 Specialty Wound Care Centers
5.4 By Mode of Purchase
5.4.1 Prescription-based (Rx)
5.4.2 Over-the-Counter (OTC)
5.5 By Country
5.5.1 United States
5.5.2 Canada
5.5.3 Mexico
6 Competitive Landscape
6.1 Market Concentration
6.2 Strategic Moves
6.3 Market Share Analysis
6.4 Company profiles ((includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
6.4.1 3M (incl. Acelity/KCI)
6.4.2 Smith & Nephew plc
6.4.3 Johnson & Johnson (Ethicon)
6.4.4 Molnlycke Health Care AB
6.4.5 ConvaTec Group PLC
6.4.6 Coloplast A/S
6.4.7 Medtronic plc
6.4.8 Baxter International Inc.
6.4.9 Becton, Dickinson and Company
6.4.10 Cardinal Health
6.4.11 Integra LifeSciences
6.4.12 Hollister Incorporated
6.4.13 Medline Industries LP
6.4.14 Organogenesis Holdings Inc.
6.4.15 MiMedx Group Inc.
6.4.16 Derma Sciences (An Integra Brand)
6.4.17 Urgo Medical
6.4.18 Advancis Medical
6.4.19 B. Braun Melsungen AG
6.4.20 Axio Biosolutions
6.4.21 Essity (Leukoplast)
6.4.22 Triad Life Sciences
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security